Emergent BioSolutions Statistics
Total Valuation
EBS has a market cap or net worth of $435.99 million. The enterprise value is $860.29 million.
Important Dates
The last earnings date was Thursday, April 30, 2026, after market close.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
EBS has 51.60 million shares outstanding. The number of shares has decreased by -1.26% in one year.
| Current Share Class | 51.60M |
| Shares Outstanding | 51.60M |
| Shares Change (YoY) | -1.26% |
| Shares Change (QoQ) | +7.82% |
| Owned by Insiders (%) | 2.00% |
| Owned by Institutions (%) | 91.95% |
| Float | 50.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.64 |
| Forward PS | 0.73 |
| PB Ratio | 0.84 |
| P/TBV Ratio | 8.27 |
| P/FCF Ratio | 3.22 |
| P/OCF Ratio | 2.95 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 5.16, with an EV/FCF ratio of 6.35.
| EV / Earnings | n/a |
| EV / Sales | 1.27 |
| EV / EBITDA | 5.16 |
| EV / EBIT | 11.42 |
| EV / FCF | 6.35 |
Financial Position
The company has a current ratio of 4.29, with a Debt / Equity ratio of 1.12.
| Current Ratio | 4.29 |
| Quick Ratio | 1.90 |
| Debt / Equity | 1.12 |
| Debt / EBITDA | 3.51 |
| Debt / FCF | 4.32 |
| Interest Coverage | 1.35 |
Financial Efficiency
Return on equity (ROE) is -1.60% and return on invested capital (ROIC) is -20.02%.
| Return on Equity (ROE) | -1.60% |
| Return on Assets (ROA) | 3.43% |
| Return on Invested Capital (ROIC) | -20.02% |
| Return on Capital Employed (ROCE) | 6.43% |
| Weighted Average Cost of Capital (WACC) | -6.09% |
| Revenue Per Employee | $752,000 |
| Profits Per Employee | -$9,556 |
| Employee Count | 900 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 1.11 |
Taxes
In the past 12 months, EBS has paid $12.10 million in taxes.
| Income Tax | 12.10M |
| Effective Tax Rate | 345.71% |
Stock Price Statistics
The stock price has increased by +31.42% in the last 52 weeks. The beta is 2.33, so EBS's price volatility has been higher than the market average.
| Beta (5Y) | 2.33 |
| 52-Week Price Change | +31.42% |
| 50-Day Moving Average | 8.32 |
| 200-Day Moving Average | 9.74 |
| Relative Strength Index (RSI) | 50.39 |
| Average Volume (20 Days) | 747,725 |
Short Selling Information
The latest short interest is 9.78 million, so 18.95% of the outstanding shares have been sold short.
| Short Interest | 9.78M |
| Short Previous Month | 9.65M |
| Short % of Shares Out | 18.95% |
| Short % of Float | 19.33% |
| Short Ratio (days to cover) | 15.44 |
Income Statement
In the last 12 months, EBS had revenue of $676.80 million and -$8.60 million in losses. Loss per share was -$0.21.
| Revenue | 676.80M |
| Gross Profit | 321.40M |
| Operating Income | 75.30M |
| Pretax Income | 3.50M |
| Net Income | -8.60M |
| EBITDA | 166.70M |
| EBIT | 75.30M |
| Loss Per Share | -$0.21 |
Full Income StatementBalance Sheet
The company has $160.30 million in cash and $584.60 million in debt, with a net cash position of -$424.30 million or -$8.22 per share.
| Cash & Cash Equivalents | 160.30M |
| Total Debt | 584.60M |
| Net Cash | -424.30M |
| Net Cash Per Share | -$8.22 |
| Equity (Book Value) | 523.10M |
| Book Value Per Share | 10.10 |
| Working Capital | 488.90M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $148.00 million and capital expenditures -$12.60 million, giving a free cash flow of $135.40 million.
| Operating Cash Flow | 148.00M |
| Capital Expenditures | -12.60M |
| Depreciation & Amortization | 91.40M |
| Net Borrowing | -112.50M |
| Free Cash Flow | 135.40M |
| FCF Per Share | $2.62 |
Full Cash Flow StatementMargins
Gross margin is 47.49%, with operating and profit margins of 11.13% and -1.27%.
| Gross Margin | 47.49% |
| Operating Margin | 11.13% |
| Pretax Margin | 0.52% |
| Profit Margin | -1.27% |
| EBITDA Margin | 24.63% |
| EBIT Margin | 11.13% |
| FCF Margin | 20.01% |
Dividends & Yields
EBS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.26% |
| Shareholder Yield | 1.26% |
| Earnings Yield | -1.97% |
| FCF Yield | 31.06% |
Analyst Forecast
The average price target for EBS is $12.00, which is 42.01% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.00 |
| Price Target Difference | 42.01% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 4.68% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
EBS has an Altman Z-Score of 1.33 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.33 |
| Piotroski F-Score | 5 |
